Category: Biosimilars
Global Biosimilars
-
Downstream Processing Market By Technology (Purification, Separation, Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Membrane Adsorbers, Other Products), By System (Single Use System, Re Usable System), By Application (Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Other Applications), By End User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs)): Global Opportunity Analysis and Industry Forecast, 2020-2030
... Production, Immunoglobulin Production, Erythropoietin Production, Other Applications), By End User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs)): Global Opportunity Analysis and Industry Forecast, 2020-2030 Downstream processing refers to the recovery and purification of biosynthetic products, particularly ... Read More
-
Global Realtime Bioprocess Raman Analyzer Market – Analysis By Product (Handheld, Bench Top, Wall Mount Raman), Component, End-User, By Region, By Country (2022 Edition): Market Insights and Forecast with Impact of COVID-19 (2022-2027)
... The Global Realtime Bioprocess Raman Analyzer Market was valued at USD 471.15 in the year 2021. The coronavirus pandemic generated lucrative opportunities for players in the real-time bioprocess Raman analyzer industry in the short-term. Improvements ... Read More
-
Global Biosimilars Market 2022-2028
... and reviewed by the FDA to ensure the biosimilar meets the Agency’s appropriately high approval standards. According to market research study published by Gen Consulting Company, the global biosimilars market is expected to reach approximately ... Read More
-
Global Biopharmaceutical CMO And CRO Market Size study, by Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars) and Regional Forecasts 2022-2028
... approximately USD 27.6 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.6 % over the forecast period 2022-2028. Biopharmaceutical CMO And CRO are contract manufacturing organizations and ... Read More
-
Global Biosimilars Market Size & Share to 2027
... others, by therapy type such as Immunology, Oncology, Hematology, Hormone Therapy, Metabolic Disorders, and Others), By Therapy Type, By Distribution Channel, By Region and Forecast till 2027 Global Biosimilars Market Biosimilars are highly identical to ... Read More
-
Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin), By Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028
... Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028 Global Biosimilars Market is valued at approximately USD 15.60 Billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Global Human Insulin Market Size study, By Product Type (Insulin Analogs and Biosimilars (Rapid-acting, Long-acting, Premixed), Human Insulin Biologics (Short-acting, Intermediate-acting, Premixed)), By Type (Insulin Analogs and Biosimilars (Long-Acting Biosimilars, Rapid-Acting Biosimilars, Premixed Biosimilars), HI Biologics (Short-Acting Biologics, Intermediate-Acting Biologics, Premixed Biologics)), By Delivery Devices (Pens, Pen Needles, Syringes), By Brand (Insulin Analogs and Biosimilars (Lantus, NovoRapid/Novolog, Humalog, Other Brands), Human Insulin Biologics (Actrapid, Insulatard, and Mixtard, Humulin, Insuman)), By Application (Type I Diabetes, Type II Diabetes), and Regional Forecasts 2022-2028
... Biologics (Short-Acting Biologics, Intermediate-Acting Biologics, Premixed Biologics)), By Delivery Devices (Pens, Pen Needles, Syringes), By Brand (Insulin Analogs and Biosimilars (Lantus, NovoRapid/Novolog, Humalog, Other Brands), Human Insulin Biologics (Actrapid, Insulatard, and Mixtard, Humulin, Insuman)), By ... Read More
-
Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer Type (Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, and Others), Route of Administration (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others)
... (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others) The metastatic cancer ... Read More
-
2022 Global Biosimilars Industry (2028 Outlook)
... market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include the total value of all products ... Read More
-
Global Protein Engineering Market Size study, By Product & Services (Instruments, Consumables, Software & Services), By Protein Type (Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-stimulating Factors, Growth Hormones, Coagulation Factors, Other Proteins), By Technology (Rational Protein Design, Irrational Protein Design), By End User (Biopharmaceutical Companies, Contract Research Organizations, Academic Research Institutes), and Regional Forecasts 2022-2028
... Design, Irrational Protein Design), By End User (Biopharmaceutical Companies, Contract Research Organizations, Academic Research Institutes), and Regional Forecasts 2022-2028 Global Protein Engineering Market is valued approximately USD 2.47 billion in 2021 and is anticipated to ... Read More
-
Global Downstream Processing Market Size study, By Product (Chromatography Columns and Resins, Filters, Membrane Adsorbers, Single-use Products, Other Products), By Technique (Purification, Solid-liquid Separation, Clarification/Concentration), By Application (Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Other Applications), By End User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs)), and Regional Forecasts 2022-2028
... Production, Erythropoietin Production, Other Applications), By End User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs)), and Regional Forecasts 2022-2028 Global Downstream Processing Market is valued approximately USD 22.05 billion in 2021 and is anticipated to grow ... Read More
-
Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Biologics and Biosimilar); Service (Process Development, Fill and Finish Operations, Analytical and Quality Control Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian), and Geography
... and Microbial-Based Biologics/Non-Mammalian), and Geography The biopharmaceutical contract manufacturing market is projected to reach US$ 27,868.50 million by 2028 from US$ 15,735.04 million in 2021; it is expected to grow at a CAGR of 8.5% ... Read More
-
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Generic Drugs Market ... Read More
-
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Application: Chemotherapy Induced Neutropenia; Transplantation; Others 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail-Order Pharmacies Covering: Coherus BioSciences; Biocon/Mylan; Sandoz (Novartis); Intas Biopharmaceuticals Ltd.; Mundipharma GmbH
... pegfilgrastim biosimilars market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
Global Healthcare Digital Experience Platform Market By Component (Platform (without services), and Services), By Application (Business-to-Consumer (B2C), Business-to-Business (B2B), and Others), By Delivery Mode (Cloud and On-premise), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
... 2021 - 2027 The Global Healthcare Digital Experience Platform Market size is expected to reach $2.1 billion by 2027, rising at a market growth of 12.8% CAGR during the forecast period. The term Digital Experience ... Read More
-
Global Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)
... research report, the global Biologics CDMO Market was valued at USD 9.9 Billion in the year 2020. Growth opportunities for the Biologics CDMO market is attributed to the growth of the geriatric population, rising technical ... Read More
-
Global Biopharmaceutical CMO And CRO Market Size study, by Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars) and Regional Forecasts 2021-2027
... approximately USD 27.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.6 % over the forecast period 2021-2027. Biopharmaceutical CMO And CRO are contract manufacturing organizations and ... Read More
-
2022 Global Forecast for Cardiac Safety Services (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Next-Generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Area (Oncology and Autoimmune or Inflammatory) and Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Fc Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins, and Biosimilar Antibody Products
... Biosimilar Antibody Products The global next-generation antibody market is expected to reach US$ 12,050.13 million by 2028 from US$ 5,428.41 million in 2021; it is estimated to grow at a CAGR of 11.9% from 2021 ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
Biosimilar Market Trends 2019
... therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed ... Read More
-
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics
... Biologics Summary The Global Biosimilar market by product is projected to grow at a compound annual growth rate (CAGR) of 45.22%. The market is driven mainly by a constrained payer environment and patent expiration of ... Read More
-
In Vitro Toxicology Market
... study aims to derive crucial insights that will benefit all the major stakeholders of the industry in developing strategic business plans based on these emerging trends. The report provides market size and growth trends for ... Read More
-
Biosimilars: Global Market, Trends and Competitor Analysis
... a complete picture of the biosimilars market, including information on the world, United States, EU, Germany, France, UK, Italy Spain, rest of Europe, Russia, Japan, India, China, South Korea, Australia, Brazil, Mexico, Turkey, Iran, Canada ... Read More
Research Assistance
